JY
OLMA icon

Jeff Yass’s Olema Pharmaceuticals OLMA Stock Holding History

Jeff Yass’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
124,952
-160,930
-56% -$2.16M ﹤0.01% 7060
2026
Q1 		$4.26M Buy
285,882
+274,658
+2,447% +$6.11M ﹤0.01% 4536
2025
Q4 		$281K Sell
11,224
-101,053
-90% -$1.8M ﹤0.01% 10099
2025
Q3 		$1.1M Buy
112,277
+19,182
+21% +$115K ﹤0.01% 7125
2025
Q2 		$397K Buy
93,095
+21,307
+30% +$95K ﹤0.01% 9713
2025
Q1 		$270K Buy
71,788
+5,568
+8% +$28K ﹤0.01% 10290
2024
Q4 		$386K Buy
66,220
+19,952
+43% +$199K ﹤0.01% 9287
2024
Q3 		$552K Sell
46,268
-19,870
-30% -$254K ﹤0.01% 8220
2024
Q2 		$716K Buy
66,138
+18,102
+38% +$196K ﹤0.01% 7360
2024
Q1 		$544K Sell
48,036
-103,831
-68% -$1.34M ﹤0.01% 8304
2023
Q4 		$2.13M Buy
151,867
+116,874
+334% +$1.57M ﹤0.01% 5210
2023
Q3 		$432K Buy
34,993
+24,921
+247% +$254K ﹤0.01% 8573
2023
Q2 		$91K Sell
10,072
-77,944
-89% -$471K ﹤0.01% 11018
2023
Q1 		$305K Buy
+88,016
New +$359K ﹤0.01% 9683
2022
Q4 		– Sell
-12,622
Closed -$36.8K – 13309
2022
Q3 		$35K Sell
12,622
-14,548
-54% -$61.7K ﹤0.01% 12397
2022
Q2 		$111K Sell
27,170
-14,251
-34% -$45.2K ﹤0.01% 11380
2022
Q1 		$176K Sell
41,421
-249,833
-86% -$1.38M ﹤0.01% 11391
2021
Q4 		$2.73M Buy
+291,254
New +$6.03M ﹤0.01% 4823
2021
Q2 		– Sell
-43,254
Closed -$1.44M – 13044
2021
Q1 		$1.44M Buy
43,254
+155
+0.4% +$6.64K ﹤0.01% 6768
2020
Q4 		$2.07M Buy
+43,099
New +$2.02M ﹤0.01% 5019

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's OLMA Position: Q2 2026 in Review

Jeff Yass reduced its Olema Pharmaceuticals (OLMA) stake by 56% in Q2 2026, selling an estimated $2.16M and leaving 124,952 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #7060.

Jeff Yass first reported a position in OLMA in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.26M in Q1 2026. 183 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jeff Yass held 124,952 shares of Olema Pharmaceuticals worth $1.56M as of Q2 2026.
  • Jeff Yass sold 160,930 Olema Pharmaceuticals shares in Q2 2026, an estimated $2.16M.
  • Olema Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7060 holding.
  • Jeff Yass first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • Jeff Yass's Olema Pharmaceuticals position peaked at $4.26M in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.